Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference46 articles.
1. National Institute for Health and Care Excellence (NICE). [PMG36] NICE health technology evaluations: the manual. 2022. Updated: 31 January 2022. Available from: https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation. Accessed 17 Feb 2022.
2. National Institute for Health and Care Excellence (NICE). Reviewing our methods for health technology evaluation: consultation. 2020. Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/chte-methods-consultation. Accessed 29 Mar 2022.
3. Rizzardo S, Bansback N, Dragojlovic N, Douglas C, Li KH, Mitton C, et al. Evaluating Canadians’ values for drug coverage decision making. Value Health. 2019;22(3):362–9. https://doi.org/10.1016/j.jval.2018.08.008.
4. Chim L, Salkeld G, Kelly P, Lipworth W, Hughes DA, Stockler MR. Societal perspective on access to publicly subsidised medicines: a cross sectional survey of 3080 adults in Australia. PLoS ONE. 2017;12(3): e0172971. https://doi.org/10.1371/journal.pone.0172971.
5. Gu Y, Lancsar E, Ghijben P, Butler JR, Donaldson C. Attributes and weights in health care priority setting: a systematic review of what counts and to what extent. Soc Sci Med. 2015;146:41–52. https://doi.org/10.1016/j.socscimed.2015.10.005.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献